AlliendCorp_logo.png
Allied Corp Increases Intellectual Property Protection by Filing Trademark for Pharma Product PSILONEX
March 25, 2021 08:55 ET | Allied Corp.
KELOWNA, British Columbia, March 25, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) an international medical company focused on creating and providing health...
ehave-logo.png
Psilocybin Data Study Agreement Reached Between Ehave Inc. and Silo Wellness Using Brain Scientific Mapping Neurocap
March 23, 2021 07:00 ET | Ehave
MIAMI, March 23, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF), a provider of digital therapeutics for the psychedelic and mental health sectors, and Silo Wellness Inc. (CSE: SILO) (“Silo...
CoreOneLabs_LOGO_COL_LRG_300dpi.png
Repeat: Core One Labs Files Application to List its Common Shares on NASDAQ
March 22, 2021 09:00 ET | Core One Labs Inc.
VANCOUVER, British Columbia, March 22, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (“Core One” or the “Company”) is pleased to announce that...
CoreOneLabs_LOGO_COL_LRG_300dpi.png
Core One Labs Files Application to List its Common Shares on NASDAQ
March 20, 2021 16:00 ET | Core One Labs Inc.
VANCOUVER, British Columbia, March 20, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (“Core One” or the “Company”) is pleased to announce that...
MagicMed Industries to Present at the Q1 Virtual Investor Summit
March 19, 2021 08:15 ET | MagicMed Industries Inc.
CALGARY, Alberta, March 19, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- MagicMed Industries Inc. ("MagicMed" or the "Company"), a biotechnology company focused on creating novel psychedelic...
AlliendCorp_logo.png
Allied Files Provisional Patent for Psilocybin Therapeutic Invention Seeking Drug Indication for Mental Health Depression and Anxiety Applications
March 18, 2021 08:55 ET | Allied Corp.
KELOWNA, British Columbia, March 18, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied") (OTCQB: ALID), an international medical cannabis company focused on creating and providing targeted psilocybin...
87520785_101152591495741_6497961433500745728_o.jpg
Mycotopia Therapies (20/20 Global) to Launch PsyBioMed, a Biosynthetic Compound, a Biotech Company for the Global Production of Psychedelics
February 08, 2021 08:30 ET | 20/20 Global, Inc.
MIAMI, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies (20/20 Global, Inc.), (OTC Pink: TWGL), a company focused on psychedelic therapies, is establishing a biosynthetic compound subsidiary...
87520785_101152591495741_6497961433500745728_o.jpg
20/20 Global Announces It Has Applied for a Name and Stock Symbol Change with FINRA
February 08, 2021 08:00 ET | 20/20 Global, Inc.
MIAMI, Feb. 08, 2021 (GLOBE NEWSWIRE) -- 20/20 Global, Inc., (OTC Pink: TWGL) “Mycotopia”, a company focused on psychedelic therapies, announced today that it has applied to the Financial Industry...
AlliendCorp_logo.png
Allied Completes Acquisition of Pacific Sun Fungi: A Leader in the Psilocybin Space
February 02, 2021 08:55 ET | Allied Corp.
KELOWNA, British Columbia, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied") (OTCQB: ALID) – an international medical company focused on creating and providing health solutions to address...
BC Craft Logo.JPG
REPEAT -- BC Craft Supply Co Announces Letter of Intent with Psilocybin Research and Development Company Ava Pathways
January 19, 2021 07:30 ET | BC Craft Supply Co. Ltd.
VANCOUVER, British Columbia, Jan. 19, 2021 (GLOBE NEWSWIRE) -- BC Craft Supply Co. Ltd. (the “Company” or “BC Craft”) (CSE: CRFT) (OTC:CRFTF) (FSE:ZZD1) is pleased to announce that it entered into a...